• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
50,865.93 926.15
(1.85%)
Dow Jones
7,414.60 126.61
(1.74%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.34 -0.07
(-0.08%)
EUR-INR
110.08 -0.10
(-0.09%)
GBP-INR
127.59 -0.01
(-0.01%)
JPY-INR
0.59 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Glenmark Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532296
INE935A01035
855.7849313
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLENMARK
37.82
60513.73
EPS(TTM)
Face Value()
Div & Yield %
56.7
1
0.12
 

Coastal Corporation reports consolidated net profit of Rs 9.90 crore in the March 2026 quarter
Jun 01,2026
Net profit of Coastal Corporation reported to Rs 9.90 crore in the quarter ended March 2026 as against net loss of Rs 1.03 crore during the previous quarter ended March 2025. Sales rose 106.69% to Rs 324.67 crore in the quarter ended March 2026 as against Rs 157.08 crore during the previous quarter ended March 2025.

For the full year,net profit rose 495.09% to Rs 26.66 crore in the year ended March 2026 as against Rs 4.48 crore during the previous year ended March 2025. Sales rose 54.51% to Rs 970.66 crore in the year ended March 2026 as against Rs 628.22 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales324.67157.08 107 970.66628.22 55
OPM %4.972.85 -6.234.86 -
PBDT17.013.28 419 50.6919.93 154
PBT12.940.05 25780 34.867.51 364
NP9.90-1.03 LP 26.664.48 495